Francesco Rossani

Clinical performance and safety of a marketed cross-linked hyaluronic acid filler with lidocaine based on full linked matrix technology: a retrospective observational study

This article is based on a retrospective observational study evaluating the clinical performance and safety profile of a marketed portfolio of cross-linked hyaluronic acid dermal fillers containing 0.3% lidocaine and manufactured using Full Linked Matrix technology. The study ret...

Clinical performance and safety of a marketed cross-linked hyaluronic acid filler with lidocaine based on full linked matrix technology: a retrospective observational study

This article is based on a retrospective observational study evaluating the clinical performance and safety profile of a marketed portfolio of cross-linked hyaluronic acid dermal fillers containing 0.3% lidocaine and manufactured using Full Linked Matrix technology. The study ret...